The Foreign Investment Review Board (FIRB) has given private equity firms The Carlyle Group and TPG Capital the green light to take over health Australian provider Healthscope Ltd (ASX:HSP).

Healthscope on Tuesday said it had been notified by FIRB that the federal government had no objection in terms of foreign investment policy to the consortium's plan to completely acquire the private hospitals and pathology operator.

TPG and Carlyle have proposed to pay Healthscope $2.7 billion, the largest takeover offer for from a private equity concern in more than four years.

In July, Healthscope directors declared that they unanimously recommend that shareholders accept a $6.26 per share cash bid from the consortium after a three-month process.

Healthscope Chairman Linda Nicholls said in her July statement: "The relative certainty delivered by this cash offer at a substantial premium was in the best interests of Healthscope shareholders. The new owners plan to "retain management and support management's strategy, business plans, and growth initiatives."

Healthscope shareholders will receive A$6.26 in cash for each share and should accept the bid, the company said, which is 39 percent higher than the stock price before Healthscope disclosed a takeover on May 14.

Directors continue to recommend to the shareholders to vote for the current proposal at the upcoming meeting on September 22 in Melbourne.

Macquarie bank is believed to be the chief creditor to the TPG-Carlyle consortium buying Healthscope, with the banker having about $150 million in committed funds out of total funded facilities of $1.2 billion and another $300m in committed but undrawn funds.

Healthscope stocks were up three cents or 0.49 per cent at $6.17 by 1019 AEST.